Establishing the pathogenic mechanism that links variants in GBA1 to PD has been challenging and unsuccessful in part due to the low penetrance of PD among all patients with GD type 1 and the long time to outcome from diagnosis of GD to clinical expression of PD. The gene discussed is GBA1; the disease is Parkinson disease.